Invasive fungal infections associated with prior respiratory viral infections in immunocompromised hosts

Infection

Volumn 46, Issue 4, 2018, Pages 555-558

  Ajmal, Saira ^a   Mahmood, Maryam ^a   Abu Saleh, Omar ^a   Larson, Jenifer ^a   Sohail, M Rizwan ^a,b  

^a MAYO CLINIC   (United States)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

Fungal infection; Immunocompromised host; Influenza; Pulmonary invasive fungal infection; RSV

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; OSELTAMIVIR; POSACONAZOLE; RIBAVIRIN; VORICONAZOLE;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTIFUNGAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; ASPERGILLOSIS; BACTERIAL SUPERINFECTION; CHARLSON COMORBIDITY INDEX; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HISTOPLASMOSIS; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLUENZA; MALE; MIDDLE AGED; MUCORMYCOSIS; PROPHYLAXIS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SYSTEMIC MYCOSIS; VIRAL RESPIRATORY TRACT INFECTION; COMORBIDITY; COMPLICATION; DISEASE MANAGEMENT; HEALTH SURVEY; IMMUNOLOGY; OUTCOME ASSESSMENT; PNEUMONIA; RISK ASSESSMENT; RISK FACTOR; VIROLOGY; VIRUS INFECTION;

AGED; ANTIFUNGAL AGENTS; COMORBIDITY; DISEASE MANAGEMENT; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INVASIVE FUNGAL INFECTIONS; MALE; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; PNEUMONIA; PUBLIC HEALTH SURVEILLANCE; RISK ASSESSMENT; RISK FACTORS; VIRUS DISEASES;

EID: 85045046458     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-018-1138-0     Document Type: Article

References (10)

1. Cadena J, Thompson GR, Patterson TF. Invasive aspergillosis current strategies for diagnosis and management. Infect Dis Clin N Am. 2016;30:125. 10.1016/j.idc.2015.10.015.
2. Alshabani K, Haq A, Miyakawa R, Palla M, Soubani AO. Invasive pulmonary aspergillosis in patients with influenza infection: report of two cases and systematic review of the literature. Expert Rev Respir Med. 2015;9:89–96. 10.1586/17476348.2015.996132.
3. Crum-Cianflone NF. Invasive aspergillosis associated with severe influenza infections. Open Forum Infect Dis. 2016;3:171. 10.1093/ofid/ofw171.
4. Hasejima N, Yamato K, Takezawa S, Kobayashi H, Kadoyama C. Invasive pulmonary aspergillosis associated with influenza B. Respirology. 2005;10:116–9. 10.1111/j.1440-1843.2005.00593.x.
5. Kim SH, Kim MN, Lee SO, Choi SH, Kim YS, Woo JH, et al. Fatal pandemic influenza A/H1N1 infection complicated by probable invasive pulmonary aspergillosis. Mycoses. 2012;55:189–92. 10.1111/j.1439-0507.2011.02051.x.
6. Lat A, Bhadelia N, Miko B, Furuya EY, Thompson GR 3rd. Invasive aspergillosis after pandemic (H1N1) 2009. Emerg Infect Dis. 2010;16:971–3. 10.3201/eid1606.100165.
7. Park DW, Yhi JY, Koo G, Jung SJ, Kwak HJ, Moon JY, et al. Fatal clinical course of probable invasive pulmonary aspergillosis with influenza B infection in an immunocompetent patient. Tuberc Respir Dis (Seoul). 2014;77:141–4. 10.4046/trd.2014.77.3.141.
8. Vehreschild JJ, Brockelmann PJ, Bangard C, Verheyen J, Vehreschild MJGT, Michels G, et al. Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients. Epidemiol Infect. 2012;140:1848–52. 10.1017/S0950268811002603.
9. Wauters J, Baar I, Meersseman P, Meersseman W, Dams K, De Paep R, et al. Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study. Intensive Care Med. 2012;38:1761–8. 10.1007/s00134-012-2673-2.
10. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813–21. 10.1086/588660.